Symptomatic therapy in multiple sclerosis: Big pharma should do more - Commentary

Michael Hutchinson

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Access to Document

@article{ca2b7d9a97894e22ba121a9ee6da9572,

title = "Symptomatic therapy in multiple sclerosis: Big pharma should do more - Commentary",

author = "Michael Hutchinson",

year = "2015",

month = jul,

day = "11",

doi = "10.1177/1352458515590281",

language = "English",

volume = "21",

pages = "982--983",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "8",

}

TY - JOUR

T1 - Symptomatic therapy in multiple sclerosis

T2 - Big pharma should do more - Commentary

AU - Hutchinson, Michael

PY - 2015/7/11

Y1 - 2015/7/11

UR - http://www.scopus.com/inward/record.url?scp=84985930306&partnerID=8YFLogxK

U2 - 10.1177/1352458515590281

DO - 10.1177/1352458515590281

M3 - Article

C2 - 26084346

AN - SCOPUS:84985930306

SN - 1352-4585

VL - 21

SP - 982

EP - 983

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 8

ER -